Interobserver variability of teledermoscopy: An international study

British Journal of Dermatology

Volumn 163, Issue 6, 2010, Pages 1276-1281

  Tan, E ^a   Oakley, A ^a   Soyer, H P ^b   Haskett, M ^c   Marghoob, A ^d   Jameson, M ^a   Rademaker, M ^a  

^a WAIKATO HOSPITAL   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

agreement; dermoscopy; interobserver; teledermoscopy; variability

Indexed keywords

ACTINIC KERATOSIS; ARTICLE; AUSTRALIA; BASAL CELL CARCINOMA; COMPUTER PROGRAM; DERMATOFIBROMA; DIAGNOSTIC VALUE; DYSPLASTIC NEVUS; HEMANGIOMA; HUMAN; IMAGE ANALYSIS; KERATOACANTHOMA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SPECIALIST; MELANOMA; NEVUS; NEW ZEALAND; PRIORITY JOURNAL; SEBORRHEIC KERATOSIS; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TELEDERMOSCOPY; TELEMEDICINE; UNITED STATES;

AUSTRALIA; DERMOSCOPY; HUMANS; NEW ZEALAND; OBSERVER VARIATION; REMOTE CONSULTATION; SKIN NEOPLASMS; UNITED STATES;

EID: 78649651557     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10010.x     Document Type: Article

References (50)

1. Ferrandiz L, Moreno-Ramirez D, Nieto-Garcia A, et al. Teledermatology-based presurgical management for nonmelanoma skin cancer: a pilot study. Dermatol Surg 2007; 33: 1092-8.
2. Ferrandiz L, Moreno-Ramirez D, Ruiz-de-Casas A, et al. [An economic analysis of presurgical teledermatology in patients with nonmelanoma skin cancer]. Actas Dermosifiliogr 2008; 99: 795-802.
3. Graves J, Fleischman MH, Goldstein GD,. Derm Access: a new triage system to rapidly identify suspicious skin lesions. Dermatol Surg 2006; 32: 1486-90.
4. Hsiao JL, Oh DH,. The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment. J Am Acad Dermatol 2008; 59: 260-7.
5. Kanthraj GR,. Classification and design of teledermatology practice: what dermatoses? Which technology to apply? J Eur Acad Dermatol Venereol 2009; 23: 865-75.
6. Moreno-Ramirez D, Ferrandiz L, Bernal AP, et al. Teledermatology as a filtering system in pigmented lesion clinics. J Telemed Telecare 2005; 11: 298-303.
7. Moreno-Ramirez D, Ferrandiz L, Nieto-Garcia A, et al. Store-and-forward teledermatology in skin cancer triage: experience and evaluation of 2009 teleconsultations. Arch Dermatol 2007; 143: 479-84.
8. Moreno-Ramirez D, Ferrandiz L, Nieto-Garcia A, et al. [Teledermatology]. Med Clin (Barc) 2008; 130: 496-503.
9. Moreno-Ramirez D, Ferrandiz L, Ruiz-de-Casas A, et al. Economic evaluation of a store-and-forward teledermatology system for skin cancer patients. J Telemed Telecare 2009; 15: 40-5.
10. Vestergaard ME, Macaskill P, Holt PE, et al. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159: 669-76.
11. Wollina U, Burroni M, Torricelli R, et al. Digital dermoscopy in clinical practise: a three-centre analysis. Skin Res Technol 2007; 13: 133-42.
12. Braun RP, Meier M, Pelloni F, et al. Teledermatoscopy in Switzerland: a preliminary evaluation. J Am Acad Dermatol 2000; 42: 770-5.
13. Carli P, De Giorgi V, Naldi L, et al. Reliability and inter-observer agreement of dermoscopic diagnosis of melanoma and melanocytic naevi. Dermoscopy Panel. Eur J Cancer Prev 1998; 7: 397-402.
14. Piccolo D, Smolle J, Argenziano G, et al. Teledermoscopy-results of a multicentre study on 43 pigmented skin lesions. J Telemed Telecare 2000; 6: 132-7.
15. Piccolo D, Smolle J, Wolf IH, et al. Face-to-face diagnosis vs telediagnosis of pigmented skin tumors: a teledermoscopic study. Arch Dermatol 1999; 135: 1467-71.
16. Whited JD, Hall RP, Foy ME, et al. Teledermatology's impact on time to intervention among referrals to a dermatology consult service. Telemed J E Health 2002; 8: 313-21.
17. Whited JD, Mills BJ, Hall RP, et al. A pilot trial of digital imaging in skin cancer. J Telemed Telecare 1998; 4: 108-12.
18. Fabbrocini G, Balato A, Rescigno O, et al. Telediagnosis and face-to-face diagnosis reliability for melanocytic and non-melanocytic 'pink' lesions. J Eur Acad Dermatol Venereol 2008; 22: 229-34.
19. Ferrara G, Argenziano G, Soyer HP, et al. Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot study. Tumori 2000; 86: 445-9.
20. Heal CF, Weedon D, Raasch BA, et al. Agreement between histological diagnosis of skin lesions by histopathologists and a dermato-histopathologist. Int J Dermatol 2009; 48: 1366-9.
21. Ek EW, Giorlando F, Su SY, Dieu T,. Clinical diagnosis of skin tumours: how good are we? ANZ J Surg 2005; 75: 415-20.
22. Warshaw EM, Lederle FA, Grill JP, et al. Accuracy of teledermatology for nonpigmented neoplasms. J Am Acad Dermatol 2009; 60: 579-88.
23. Tan E, Yung A, Jameson M, et al. Successful triage of patients referred to a skin lesion clinic using teledermoscopy (IMAGE IT trial). Br J Dermatol 2010; 162: 803-11.
24. Argenziano G, Soyer HP,. Dermoscopy of pigmented skin lesions-a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001; 2: 443-9.
25. Argenziano G, Soyer HP, Chimenti S, et al. Impact of dermoscopy on the clinical management of pigmented skin lesions. Clin Dermatol 2002; 20: 200-2.
26. Bafounta ML, Beauchet A, Aegerter P, et al. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137: 1343-50.
27. Binder M, Schwarz M, Winkler A, et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131: 286-91.
28. Ferrara G, Argenziano G, Soyer HP, et al. Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: an interdisciplinary study on 107 cases. Cancer 2002; 95: 1094-100.
29. Kittler H, Pehamberger H, Wolff K, et al. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3: 159-65.
30. Soyer HP, Argenziano G, Talamini R, et al. Is dermoscopy useful for the diagnosis of melanoma? Arch Dermatol 2001; 137: 1361-3.
31. Carli P, De Giorgi V, Crocetti E, et al. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol 2004; 150: 687-92.
32. Oakley AM, Astwood DR, Loane M, et al. Diagnostic accuracy of teledermatology: results of a preliminary study in New Zealand. N Z Med J 1997; 110: 51-3.
33. Piccolo D, Peris K, Chimenti S, et al. Jumping into the future using teledermoscopy. Skinmed 2002; 1: 20-4.
34. Shapiro M, Chren MM, Levy RM, et al. Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol 2004; 31: 523-30.
35. Farmer ER, Gonin R, Hanna MP,. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528-31.
36. Ackerman AB,. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 1988; 13: 241-56.
37. Shors AR, Kim S, White E, et al. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol 2006; 155: 988-93.
38. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218-23.
39. Cerroni L, Kerl H,. Tutorial on melanocytic lesions. Am J Dermatopathol 2001; 23: 237-41.
40. Wechsler J, Bastuji-Garin S, Spatz A, et al. Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol 2002; 138: 625-8.
41. Lodha S, Saggar S, Celebi JT, et al. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol 2008; 35: 349-52.
42. Shoo BA, Sagebiel RW, Kashani-Sabet M,. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol 2010; 62: 751-6.
43. Levell NJ, Beattie CC, Shuster S, et al. Melanoma epidemic: a midsummer night's dream? Br J Dermatol 2009; 161: 630-4.
44. Boldrick JC, Layton CJ, Nguyen J, et al. Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. J Am Acad Dermatol 2007; 56: 417-21.
45. Piccolo D, Soyer HP, Chimenti S, et al. Diagnosis and categorization of acral melanocytic lesions using teledermoscopy. J Telemed Telecare 2004; 10: 346-50.
46. Rubegni P, Burroni M, Cevenini G, et al. Digital dermoscopy analysis and artificial neural network for the differentiation of clinically atypical pigmented skin lesions: a retrospective study. J Invest Dermatol 2002; 119: 471-4.
47. Rubegni P, Cevenini G, Burroni M, et al. Digital dermoscopy analysis of atypical pigmented skin lesions: a stepwise logistic discriminant analysis approach. Skin Res Technol 2002; 8: 276-81.
48. Seidenari S, Longo C, Giusti F, et al. Clinical selection of melanocytic lesions for dermoscopy decreases the identification of suspicious lesions in comparison with dermoscopy without clinical preselection. Br J Dermatol 2006; 154: 873-9.
49. Tosi GM, Rubegni P, Schuerfeld K, et al. Digital surface microscopy analysis of conjunctival pigmented lesions: a preliminary study. Melanoma Res 2004; 14: 375-80.
50. Zalaudek I, Argenziano G, Ferrara G, et al. Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol 2004; 150: 64-71.